Clinical Trial: Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618793) titled 'Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma' on May 25.

Brief Summary: The goal of this clinical trial is to learn if adding intermittent hypoxic training (IHT) to standard neoadjuvant chemo-immunotherapy can increase the pathologic complete response (pCR) rate in patients aged 18 to 75 of both sexes with resectable stage II-IIIA lung squamous cell carcinoma. The main questions it aims to answer are:Can the addition of IHT to standard neoadjuvant chemo-immunotherapy significantly improve the pathologic complete response (pCR) rate compared to standard therapy alone? Is IHT safe and well-toler...